Human CD2/T11 ORF/cDNA clone-Lentivirus particle (BC033583)
Cat. No.: vGMLP004069
Pre-made Human CD2/T11 Lentiviral expression plasmid for CD2 lentivirus packaging, CD2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CD2/T11 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP004069 | Human CD2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP004069 |
| Gene Name | CD2 |
| Accession Number | BC033583 |
| Gene ID | 914 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 1056 bp |
| Gene Alias | T11 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGCTTTCCATGTAAATTTGTAGCCAGCTTCCTTCTGATTTTCAATGTTTCTTCCAAAGGTGCAGTCTCCAAAGAGATTACGAATGCCTTGGAAACCTGGGGTGCCTTGGGTCAGGACATCAACTTGGACATTCCTAGTTTTCAAATGAGTGATGATATTGACGATATAAAATGGGAAAAAACTTCAGACAAGAAAAAGATTGCACAATTCAGAAAAGAGAAAGAGACTTTCAAGGAAAAAGATACATATAAGCTATTTAAAAATGGAACTCTGAAAATTAAGCATCTGAAGACCGATGATCAGGATATCTACAAGGTATCAATATATGATACAAAAGGAAAAAATGTGTTGGAAAAAATATTTGATTTGAAGATTCAAGAGAGGGTCTCAAAACCAAAGATCTCCTGGACTTGTATCAACACAACCCTGACCTGTGAGGTAATGAATGGAACTGACCCCGAATTAAACCTGTATCAAGATGGGAAACATCTAAAACTTTCTCAGAGGGTCATCACACACAAGTGGACCACCAGCCTGAGTGCAAAATTCAAGTGCACAGCAGGGAACAAAGTCAGCAAGGAATCCAGTGTCGAGCCTGTCAGCTGTCCAGAGAAAGGTCTGGACATCTATCTCATCATTGGCATATGTGGAGGAGGCAGCCTCTTGATGGTCTTTGTGGCACTGCTCGTTTTCTATATCACCAAAAGGAAAAAACAGAGGAGTCGGAGAAATGATGAGGAGCTGGAGACAAGAGCCCACAGAGTAGCTACTGAAGAAAGGGGCCGGAAGCCCCAACAAATTCCAGCTTCAACCCCTCAGAATCCAGCAACTTCCCAACATCCTCCTCCACCACCTGGTCATCGTTCCCAGGCACCTAGTCATCGTCCCCCGCCTCCTGGACACCGTGTTCAGCACCAGCCTCAGAAGAGGCCTCCTGCTCCGTCGGGCACACAAGTTCACCAGCAGAAAGGCCCGCCCCTCCCCAGACCTCGAGTTCAGCCAAAACCTCCCCATGGGGCAGCAGAAAACTCATTGTCCCCTTCCTCTAATTAA |
| ORF Protein Sequence | MSFPCKFVASFLLIFNVSSKGAVSKEITNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKEKDTYKLFKNGTLKIKHLKTDDQDIYKVSIYDTKGKNVLEKIFDLKIQERVSKPKISWTCINTTLTCEVMNGTDPELNLYQDGKHLKLSQRVITHKWTTSLSAKFKCTAGNKVSKESSVEPVSCPEKGLDIYLIIGICGGGSLLMVFVALLVFYITKRKKQRSRRNDEELETRAHRVATEERGRKPQQIPASTPQNPATSQHPPPPPGHRSQAPSHRPPPPGHRVQHQPQKRPPAPSGTQVHQQKGPPLPRPRVQPKPPHGAAENSLSPSSN |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-INN-729 | Pre-Made Alefacept Biosimilar, Fusion Protein targeting CD2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting LFA-2/SRBC/T11 |
| Biosimilar | GMP-Bios-INN-992 | Pre-Made Siplizumab Biosimilar, Whole Mab, Anti-Cd2 Antibody: Anti-LFA-2/SRBC/T11 therapeutic antibody |
| Target Antibody | GM-Tg-g-T02532-Ab | Anti-CD2/ LFA-2/ SRBC monoclonal antibody |
| Target Antigen | GM-Tg-g-T02532-Ag | CD2 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP004069 | Human CD2 Lentivirus plasmid |
| ORF Viral Vector | vGMLP004069 | Human CD2 Lentivirus particle |
Target information
| Target ID | GM-T02532 |
| Target Name | CD2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
914 |
| Gene ID |
100034205 (Equus caballus), 12481 (Mus musculus), 493790 (Felis catus), 497022 (Bos taurus) 497761 (Rattus norvegicus), 607448 (Canis lupus familiaris), 677855 (Macaca mulatta), 914 (Homo sapiens) |
| Gene Symbols & Synonyms | CD2,Cd2,Ly37,LFA-2,Ly-37,CD2R,LFA2,OX34,OX-34,T11,SRBC |
| Target Alternative Names | CD2,CD2R,Cd2,Erythrocyte receptor,LFA-2,LFA-3 receptor,LFA2,Ly-37,Ly37,OX-34,OX34,Rosette receptor,SRBC,T-cell surface antigen CD2,T-cell surface antigen T11/Leu-5,T11 |
| Uniprot Accession |
P06729,P08920,P08921,P37998
Additional SwissProt Accessions: P37998,P08920,P08921,P06729 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, INN Index |
| Disease | |
| Disease from KEGG | Cell adhesion molecules, Hematopoietic cell lineage |
| Gene Ensembl | ENSECAG00000019437, ENSMUSG00000027863, ENSBTAG00000017256, ENSCAFG00845028984, ENSMMUG00000052649, ENSG00000116824 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


